Tourette syndrome: Gene expression as a tool to discover drug targets

Isaac H. Liao, Frank R Sharp

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gene expression microarrays are a high-throughput, cost-effective method for measuring the expression of all genes in a sample. By comparing the expression patterns of healthy controls to diseased subjects, the genetic regulatory pathways underlying and affected by the disease can be elucidated. Furthermore, dysregulated genes are possible candidates for pharmaceutical therapy. Here, we consider the possibility of applying this approach to Tourette syndrome. We also review current theories of Tourette syndrome etiology and pharmacology.

Original languageEnglish (US)
Pages (from-to)302-306
Number of pages5
JournalNeurotherapeutics
Volume7
Issue number3
DOIs
StatePublished - Jul 2010

Fingerprint

Tourette Syndrome
Gene Expression
Inborn Genetic Diseases
Pharmaceutical Preparations
Pharmacology
Costs and Cost Analysis
Genes
Therapeutics

Keywords

  • Gene expression
  • Microarrays
  • Pharmacology
  • Tourette syndrome

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology
  • Medicine(all)

Cite this

Tourette syndrome : Gene expression as a tool to discover drug targets. / Liao, Isaac H.; Sharp, Frank R.

In: Neurotherapeutics, Vol. 7, No. 3, 07.2010, p. 302-306.

Research output: Contribution to journalArticle

@article{511a5f164b304078ac8e3ebbd0afb154,
title = "Tourette syndrome: Gene expression as a tool to discover drug targets",
abstract = "Gene expression microarrays are a high-throughput, cost-effective method for measuring the expression of all genes in a sample. By comparing the expression patterns of healthy controls to diseased subjects, the genetic regulatory pathways underlying and affected by the disease can be elucidated. Furthermore, dysregulated genes are possible candidates for pharmaceutical therapy. Here, we consider the possibility of applying this approach to Tourette syndrome. We also review current theories of Tourette syndrome etiology and pharmacology.",
keywords = "Gene expression, Microarrays, Pharmacology, Tourette syndrome",
author = "Liao, {Isaac H.} and Sharp, {Frank R}",
year = "2010",
month = "7",
doi = "10.1016/j.nurt.2010.05.007",
language = "English (US)",
volume = "7",
pages = "302--306",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Tourette syndrome

T2 - Gene expression as a tool to discover drug targets

AU - Liao, Isaac H.

AU - Sharp, Frank R

PY - 2010/7

Y1 - 2010/7

N2 - Gene expression microarrays are a high-throughput, cost-effective method for measuring the expression of all genes in a sample. By comparing the expression patterns of healthy controls to diseased subjects, the genetic regulatory pathways underlying and affected by the disease can be elucidated. Furthermore, dysregulated genes are possible candidates for pharmaceutical therapy. Here, we consider the possibility of applying this approach to Tourette syndrome. We also review current theories of Tourette syndrome etiology and pharmacology.

AB - Gene expression microarrays are a high-throughput, cost-effective method for measuring the expression of all genes in a sample. By comparing the expression patterns of healthy controls to diseased subjects, the genetic regulatory pathways underlying and affected by the disease can be elucidated. Furthermore, dysregulated genes are possible candidates for pharmaceutical therapy. Here, we consider the possibility of applying this approach to Tourette syndrome. We also review current theories of Tourette syndrome etiology and pharmacology.

KW - Gene expression

KW - Microarrays

KW - Pharmacology

KW - Tourette syndrome

UR - http://www.scopus.com/inward/record.url?scp=77954903756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954903756&partnerID=8YFLogxK

U2 - 10.1016/j.nurt.2010.05.007

DO - 10.1016/j.nurt.2010.05.007

M3 - Article

C2 - 20643383

AN - SCOPUS:77954903756

VL - 7

SP - 302

EP - 306

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 3

ER -